ID IL9_MOUSE Reviewed; 144 AA. AC P15247; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1990, sequence version 1. DT 27-MAR-2024, entry version 154. DE RecName: Full=Interleukin-9; DE Short=IL-9; DE AltName: Full=Cytokine P40; DE AltName: Full=T-cell growth factor P40; DE Flags: Precursor; GN Name=Il9; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; RX PubMed=2521242; DOI=10.1084/jem.169.1.363; RA van Snick J., Goethals A., Renauld J.-C., van Roost E., Uyttenhove C., RA Rubira M.R., Moritz R.L., Simpson R.J.; RT "Cloning and characterization of a cDNA for a new mouse T cell growth RT factor (P40)."; RL J. Exp. Med. 169:363-368(1989). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=1971295; RA Renauld J.-C., Goethals A., Houssiau F., Merz H., van Roost E., RA van Snick J.; RT "Human P40/IL-9. Expression in activated CD4+ T cells, genomic RT organization, and comparison with the mouse gene."; RL J. Immunol. 144:4235-4241(1990). RN [3] RP PROTEIN SEQUENCE OF 19-144, PYROGLUTAMATE FORMATION AT GLN-19, AND RP GLYCOSYLATION AT ASN-50; ASN-78; ASN-101 AND ASN-114. RX PubMed=2528451; DOI=10.1111/j.1432-1033.1989.tb21103.x; RA Simpson R.J., Moritz R.L., Rubira M.R., Gorman J.J., van Snick J.; RT "Complete amino acid sequence of a new murine T-cell growth factor P40."; RL Eur. J. Biochem. 183:715-722(1989). RN [4] RP PROTEIN SEQUENCE OF 118-136. RX PubMed=3137580; DOI=10.1073/pnas.85.18.6934; RA Uyttenhove C., Simpson R.J., van Snick J.; RT "Functional and structural characterization of P40, a mouse glycoprotein RT with T-cell growth factor activity."; RL Proc. Natl. Acad. Sci. U.S.A. 85:6934-6938(1988). RN [5] RP FUNCTION, AND INTERACTION WITH IL9R. RX PubMed=2145361; RA Druez C., Coulie P., Uyttenhove C., Van Snick J.; RT "Functional and biochemical characterization of mouse P40/IL-9 receptors."; RL J. Immunol. 145:2494-2499(1990). RN [6] RP FUNCTION, AND INTERACTION WITH IL2RG. RX PubMed=7718508; DOI=10.1093/intimm/7.1.115; RA Kimura Y., Takeshita T., Kondo M., Ishii N., Nakamura M., Van Snick J., RA Sugamura K.; RT "Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor RT complex."; RL Int. Immunol. 7:115-120(1995). RN [7] RP FUNCTION. RX PubMed=10464327; DOI=10.1074/jbc.274.36.25855; RA Demoulin J.B., Van Roost E., Stevens M., Groner B., Renauld J.C.; RT "Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene RT induction and apoptosis inhibition by interleukin-9."; RL J. Biol. Chem. 274:25855-25861(1999). RN [8] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=11070175; DOI=10.1016/s1074-7613(00)00056-x; RA Townsend J.M., Fallon G.P., Matthews J.D., Smith P., Jolin E.H., RA McKenzie N.A.; RT "IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary RT mastocytosis and goblet cell hyperplasia but not T cell development."; RL Immunity 13:573-583(2000). RN [9] RP FUNCTION. RX PubMed=12704113; DOI=10.1128/iai.71.5.2430-2438.2003; RA Khan W.I., Richard M., Akiho H., Blennerhasset P.A., Humphreys N.E., RA Grencis R.K., Van Snick J., Collins S.M.; RT "Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL- RT 9 neutralization: correlation with worm expulsion in murine nematode RT infections."; RL Infect. Immun. 71:2430-2438(2003). RN [10] RP FUNCTION. RX PubMed=19433802; DOI=10.1073/pnas.0812530106; RA Elyaman W., Bradshaw E.M., Uyttenhove C., Dardalhon V., Awasthi A., RA Imitola J., Bettelli E., Oukka M., van Snick J., Renauld J.C., RA Kuchroo V.K., Khoury S.J.; RT "IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ RT natural regulatory T cells."; RL Proc. Natl. Acad. Sci. U.S.A. 106:12885-12890(2009). CC -!- FUNCTION: Multifunctional cytokine secreted mainly by T-helper 2 CC lymphocytes and also mast cells or NKT cells that plays important roles CC in the immune response against parasites (PubMed:11070175, CC PubMed:19433802). Affects intestinal epithelial permeability and CC adaptive immunity (PubMed:12704113). In addition, induces the CC differentiation of specific T-cell subsets such as IL-17 producing CC helper T-cells (TH17) and also proliferation and differentiation of CC mast cells (PubMed:19433802, PubMed:11070175). Mechanistically, exerts CC its biological effects through a receptor composed of IL9R subunit and CC a signal transducing subunit IL2RG (PubMed:2145361, PubMed:7718508). CC Receptor stimulation results in the rapid activation of JAK1 and JAK3 CC kinase activities leading to STAT1, STAT3 and STAT5-mediated CC transcriptional programs (PubMed:10464327). Induction of CC differentiation genes seems to be mediated by STAT1 alone, while CC protection of cells from apoptosis depends on STAT3 and STAT5 CC (PubMed:10464327). {ECO:0000269|PubMed:10464327, CC ECO:0000269|PubMed:11070175, ECO:0000269|PubMed:12704113, CC ECO:0000269|PubMed:19433802, ECO:0000269|PubMed:2145361, CC ECO:0000269|PubMed:7718508}. CC -!- SUBUNIT: Interacts with IL9R (PubMed:2145361). Interacts with IL2RG CC (PubMed:7718508). {ECO:0000269|PubMed:2145361, CC ECO:0000269|PubMed:7718508}. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- DISRUPTION PHENOTYPE: Deltion mice do not show defects in T-cell CC development or differentiation, the generation of naive or antigen- CC driven antibody responses, or the expulsion of the intestinal parasitic CC nematode Nippostrongylus brasiliensis. However, mastocytosis is CC severely impaired in these animals. {ECO:0000269|PubMed:19433802}. CC -!- SIMILARITY: Belongs to the IL-7/IL-9 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X14045; CAA32203.1; -; mRNA. DR EMBL; M30136; AAA39874.1; -; Genomic_DNA. DR CCDS; CCDS26562.1; -. DR PIR; JL0089; JL0089. DR RefSeq; NP_032399.1; NM_008373.1. DR PDB; 7OX4; X-ray; 1.80 A; C=19-144. DR PDB; 7XCB; X-ray; 3.40 A; A=21-140. DR PDBsum; 7OX4; -. DR PDBsum; 7XCB; -. DR AlphaFoldDB; P15247; -. DR SMR; P15247; -. DR STRING; 10090.ENSMUSP00000022019; -. DR GlyCosmos; P15247; 4 sites, No reported glycans. DR GlyGen; P15247; 4 sites. DR iPTMnet; P15247; -. DR PhosphoSitePlus; P15247; -. DR PaxDb; 10090-ENSMUSP00000022019; -. DR Antibodypedia; 14762; 745 antibodies from 39 providers. DR DNASU; 16198; -. DR Ensembl; ENSMUST00000022019.4; ENSMUSP00000022019.4; ENSMUSG00000021538.4. DR GeneID; 16198; -. DR KEGG; mmu:16198; -. DR UCSC; uc007qso.1; mouse. DR AGR; MGI:96563; -. DR CTD; 3578; -. DR MGI; MGI:96563; Il9. DR VEuPathDB; HostDB:ENSMUSG00000021538; -. DR eggNOG; ENOG502TDE1; Eukaryota. DR GeneTree; ENSGT00390000015384; -. DR HOGENOM; CLU_150120_0_0_1; -. DR InParanoid; P15247; -. DR OMA; IPSDNCP; -. DR OrthoDB; 5260311at2759; -. DR PhylomeDB; P15247; -. DR TreeFam; TF336367; -. DR Reactome; R-MMU-8985947; Interleukin-9 signaling. DR BioGRID-ORCS; 16198; 2 hits in 76 CRISPR screens. DR PRO; PR:P15247; -. DR Proteomes; UP000000589; Chromosome 13. DR RNAct; P15247; Protein. DR Bgee; ENSMUSG00000021538; Expressed in epiblast cell in embryo and 10 other cell types or tissues. DR GO; GO:0005615; C:extracellular space; IDA:MGI. DR GO; GO:0005125; F:cytokine activity; IGI:MGI. DR GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW. DR GO; GO:0005140; F:interleukin-9 receptor binding; ISO:MGI. DR GO; GO:0030183; P:B cell differentiation; IGI:MGI. DR GO; GO:0042100; P:B cell proliferation; IGI:MGI. DR GO; GO:0016064; P:immunoglobulin mediated immune response; IGI:MGI. DR GO; GO:0030307; P:positive regulation of cell growth; ISO:MGI. DR GO; GO:0032754; P:positive regulation of interleukin-5 production; IMP:UniProtKB. DR GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:MGI. DR GO; GO:0046425; P:regulation of receptor signaling pathway via JAK-STAT; IDA:MGI. DR InterPro; IPR018049; IL-7/IL-9_CS. DR InterPro; IPR020447; IL-9. DR PANTHER; PTHR16926; INTERLEUKIN 9; 1. DR PANTHER; PTHR16926:SF1; INTERLEUKIN-9; 1. DR PRINTS; PR01926; INTERLEUKIN9. DR PROSITE; PS00255; INTERLEUKIN_7_9; 1. DR Genevisible; P15247; MM. PE 1: Evidence at protein level; KW 3D-structure; Cytokine; Direct protein sequencing; Glycoprotein; KW Growth factor; Pyrrolidone carboxylic acid; Reference proteome; Secreted; KW Signal. FT SIGNAL 1..18 FT /evidence="ECO:0000269|PubMed:2528451" FT CHAIN 19..144 FT /note="Interleukin-9" FT /id="PRO_0000015628" FT MOD_RES 19 FT /note="Pyrrolidone carboxylic acid" FT /evidence="ECO:0000269|PubMed:2528451" FT CARBOHYD 50 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:2528451" FT CARBOHYD 78 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:2528451" FT CARBOHYD 101 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:2528451" FT CARBOHYD 114 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:2528451" FT HELIX 24..37 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 41..44 FT /evidence="ECO:0007829|PDB:7OX4" FT STRAND 48..50 FT /evidence="ECO:0007829|PDB:7OX4" FT STRAND 57..60 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 70..79 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 83..85 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 86..101 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 105..108 FT /evidence="ECO:0007829|PDB:7OX4" FT STRAND 116..119 FT /evidence="ECO:0007829|PDB:7OX4" FT HELIX 121..138 FT /evidence="ECO:0007829|PDB:7OX4" SQ SEQUENCE 144 AA; 16075 MW; ECD944632CE837C7 CRC64; MLVTYILASV LLFSSVLGQR CSTTWGIRDT NYLIENLKDD PPSKCSCSGN VTSCLCLSVP TDDCTTPCYR EGLLQLTNAT QKSRLLPVFH RVKRIVEVLK NITCPSFSCE KPCNQTMAGN TLSFLKSLLG TFQKTEMQRQ KSRP //